
Amgen
OrganizationHeard in 9 episodes across 5 shows since Aug 2026
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. It discovers, develops, manufactures, and delivers biologic medicines for serious diseases, using biology and technology to address major unmet medical needs.
Episodes
9
across 5 shows
First heard
Aug 2026
Expert statements
2
2 negative
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
7
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 7 |
| Oct 2026 | 1 |
What experts have said about Amgen
2 statements · 2 negative
Novartis’s news is dragging down Amgen shares.
“shares of Amgen, for instance, which is also in late-stage testing of its own heart disease drug, also being dragged down as a result of this news from Novartis.”
Open the episode · Novartis Drop; Boston Scientific Cyberattack; Intel RisesListen at 1:26
Novartis’s news is dragging down Amgen shares.
“Shares of Amgen, for instance, which is in late-stage testing of its own heart disease medication, also being dragged down by this news from Novartis.”
Open the episode · Novartis and Boston Scientific Slide; Intel Price HikesListen at 1:31
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
9 episodes featuring Amgen, newest first
- Oct 7, 2026
Cramer tests consumer resilience, AI defenses and Wall Street targetsMad Money w/ Jim CramerOct 7, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 12, 2026
Oil shock pushes markets toward higher ratesWSJ What’s NewsSep 12, 2026 - Sep 8, 2026
Drug setback and cyberattack rattle major stock moversStock MoversSep 8, 2026 - Sep 8, 2026
Drug trial failure and cyberattack pressure major chipmakerStock MoversSep 8, 2026 - Sep 8, 2026
Drug trial setback rattles Amgen as Oracle and Bloom Energy riseStock MoversSep 8, 2026